N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide

C44H47N11O4 — CID 169120917

IUPACN-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide
SMILESCc1ccc(-c2nn(C3CCC(CN4CCN(CC#Cc5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)CC3)cc2NC(=O)c2ccn3cccnc23)nc1
InChIInChI=1S/C44H47N11O4/c1-29-9-14-34(46-26-29)39-35(47-42(57)33-17-21-53-20-5-18-45-41(33)53)28-54(49-39)32-12-10-30(11-13-32)27-52-24-22-51(23-25-52)19-4-7-31-6-3-8-36-40(31)50(2)44(59)55(36)37-15-16-38(56)48-43(37)58/h3,5-6,8-9,14,17-18,20-21,26,28,30,32,37H,10-13,15-16,19,22-25,27H2,1-2H3,(H,47,57)(H,48,56,58)
InChIKeyCQSDMSRMCAEVPV-UHFFFAOYSA-N
MW793.93 g/mol
LogP4.19
Rot. Bonds8

About N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide

N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide (PubChem CID 169120917) has the molecular formula C44H47N11O4 and a molecular weight of 793.93 g/mol. Its IUPAC name is N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide.

Molecular Properties

Compound NameN-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide
PubChem CID169120917
Molecular FormulaC44H47N11O4
Molecular Weight793.93 g/mol
Exact Mass793.38
IUPAC NameN-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide
SMILESCc1ccc(-c2nn(C3CCC(CN4CCN(CC#Cc5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)CC3)cc2NC(=O)c2ccn3cccnc23)nc1
InChIInChI=1S/C44H47N11O4/c1-29-9-14-34(46-26-29)39-35(47-42(57)33-17-21-53-20-5-18-45-41(33)53)28-54(49-39)32-12-10-30(11-13-32)27-52-24-22-51(23-25-52)19-4-7-31-6-3-8-36-40(31)50(2)44(59)55(36)37-15-16-38(56)48-43(37)58/h3,5-6,8-9,14,17-18,20-21,26,28,30,32,37H,10-13,15-16,19,22-25,27H2,1-2H3,(H,47,57)(H,48,56,58)
InChIKeyCQSDMSRMCAEVPV-UHFFFAOYSA-N
XLogP4.19
TPSA156.69 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds8
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500793.93
LogP ≤ 54.19
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide?
The IUPAC name of N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide (CID 169120917) is N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide.
What is the SMILES notation for N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide?
The canonical SMILES for N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide is Cc1ccc(-c2nn(C3CCC(CN4CCN(CC#Cc5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)CC3)cc2NC(=O)c2ccn3cccnc23)nc1.
What is the InChIKey of N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide?
The InChIKey is CQSDMSRMCAEVPV-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H47N11O4/c1-29-9-14-34(46-26-29)39-35(47-42(57)33-17-21-53-20-5-18-45-41(33)53)28-54(49-39)32-12-10-30(11-13-32)27-52-24-22-51(23-25-52)19-4-7-31-6-3-8-36-40(31)50(2)44(59)55(36)37-15-16-38(56)48-43(37)58/h3,5-6,8-9,14,17-18,20-21,26,28,30,32,37H,10-13,15-16,19,22-25,27H2,1-2H3,(H,47,57)(H,48,56,58).
What are the key properties of N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide?
N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide has a molecular weight of 793.93 g/mol, XLogP of 4.19, 8 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynyl]piperazin-1-yl]methyl]cyclohexyl]-3-(5-methyl-2-pyridinyl)pyrazol-4-yl]pyrrolo[1,2-a]pyrimidine-8-carboxamide is sourced from PubChem (CID 169120917), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).